International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8275162
Original Article
The Efficacy of Risk Factors for Predicting Wound Dehiscence: A Prospective and Retrospective Study
 ,
 ,
Published
Aug. 22, 2023
Abstract

INTRODUCTION: Wound dehiscence is among the most dreaded complications faced by surgeon and is of greatest concern because it leads to many other problems like increased morbidity and mortality ,prolonged  hospital stay ,economic burden on society The mortality rate following wound dehiscence ranges from 9%-43%. .there are many factors related to patient, related to disease, and also related to treatment like emergency surgery,  Intraabdominal infections, malnutrition, advance age,  systemic disease, ascites, diabetes, postoperative  coughing etc. METHOD and MATERIAL: These factors are studied in cases and there outcome are compared with control.thsi study was done in NSCB medical college Jabalpur from September 2018 to September 2020.100 cases and controls are takens and study is done Retrospective and prospective manner in those patients which are operated in institute. Details of patients are taken and compared with p value and chi square test applied and there results found. Samong all factors age, jaundice ,anaemia, hypoalbunemia, ascites, diabetes, postoperative coughing were found affecting wound dehiscence.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
1134 Views
123 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved